Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tebipenem Pivoxil Hydrobromide vs Ertapenem in cUTI and Acute Pyelonephritis
NCT03788967Phase 3Completed
- Sponsor
- Spero Therapeutics
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Drug Delivery Systems
- Countries
- 15
01
Overview
A Phase 3 trial of tebipenem in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Spero Therapeutics. Started Jun 2019; status: completed.
02
Drugs
tebipenem
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03788967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788967.